Overweight and obesity as risk factors for biochemical recurrence of prostate cancer after radical prostatectomy

被引:6
作者
Kim, Sung Jin [1 ]
Park, Min Uk [2 ]
Chae, Han Kyu [1 ]
Nam, Wook [1 ]
Kim, So Won [3 ]
Yu, Hoon [4 ]
Kim, Han Gwun [1 ]
Kang, Gil Hyun [5 ]
Park, Jong Yeon [1 ]
机构
[1] Univ Ulsan, Coll Med, Gangneung Asan Hosp, Dept Urol, Kangnung, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Urol, Seoul, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pharmacol, Seoul, South Korea
[4] Univ Ulsan, Coll Med, Gangneung Asan Hosp, Dept Nephrol, Kangnung, South Korea
[5] Univ Ulsan, Coll Med, Gangneung Asan Hosp, Dept Pathol, Kangnung, South Korea
关键词
Prostate cancer; Biochemical recurrence; Body mass index; Obesity; BODY-MASS INDEX; ANTIGEN DENSITY; ASSOCIATION; AMERICAN; MEN;
D O I
10.1007/s10147-021-02058-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Previous studies have shown a relationship between the occurrence and recurrence of prostate cancer; however, this relationship remains controversial. We investigated the relationship between obesity and biochemical recurrence in patients with prostate cancer. Methods Clinicopathological factors were analyzed after dividing the patient population according to the Asian population-specific body mass index (BMI) criteria for "normal" (< 23 kg/m(2)), "overweight" (23-27.5 kg/m(2)), and "obese" (>= 27.5 kg/m(2)). Among the 389 patients included in this study, 108 were classified as normal, while 227 and 54 patients were classified as overweight and obese, respectively. The relationships between clinicopathological factors and biochemical recurrence were analyzed by univariate and multivariate Cox <= proportional hazard models. Biochemical recurrence was defined as two consecutive prostate-specific antigen (PSA) measurements >= 0.2 ng/mL. Results In univariate analysis, the categorical variables of "overweight" and "obese" were significant prognostic factors for biochemical recurrence. In multivariate analysis models including PSA density [hazard ratio (HR) 1.8, p = 0.01], extraprostatic extension (HR 2.0, p < 0.001), Gleason score (HR 1.7, p = 0.01), surgical margin positivity (HR 2.46, p < 0.001), and lymphovascular invasion (HR 2.53, p < 0.001), the categorical variables of "overweight" (HR 1.6, p = 0.03) and "obese" (HR 1.76, p = 0.035) were prognostic factors for biochemical recurrence. Conclusion The obesity status of patients with prostate cancer as "overweight" and "obese" was a risk factor for biochemical recurrence after adjusting for other clinicopathological factors.
引用
收藏
页码:403 / 410
页数:8
相关论文
共 36 条
[21]   Obesity, Prostate-Specific Antigen Nadir, and Biochemical Recurrence After Radical Prostatectomy: Biology or Technique? Results from the SEARCH Database [J].
Ho, Tammy ;
Gerber, Leah ;
Aronson, William J. ;
Terris, Martha K. ;
Presti, Joseph C. ;
Kane, Christopher J. ;
Amling, Christopher L. ;
Freedland, Stephen J. .
EUROPEAN UROLOGY, 2012, 62 (05) :910-916
[22]   Obesity has multifaceted impact on biochemical recurrence of prostate cancer: a dose-response meta-analysis of 36,927 patients [J].
Hu, Meng-Bo ;
Xu, Hua ;
Bai, Pei-De ;
Jiang, Hao-Wen ;
Ding, Qiang .
MEDICAL ONCOLOGY, 2014, 31 (02)
[23]   Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation [J].
Iyengar, Neil M. ;
Gucalp, Ayca ;
Dannenberg, Andrew J. ;
Hudis, Clifford A. .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (35) :4270-+
[24]   Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity [J].
Laurent, Victor ;
Guerard, Adrien ;
Mazerolles, Catherine ;
Le Gonidec, Sophie ;
Toulet, Aurelie ;
Nieto, Laurence ;
Zaidi, Falek ;
Majed, Bilal ;
Garandeau, David ;
Socrier, Youri ;
Golzio, Muriel ;
Cadoudal, Thomas ;
Chaoui, Karima ;
Dray, Cedric ;
Monsarrat, Bernard ;
Schiltz, Odile ;
Wang, Yuan Yuan ;
Couderc, Bettina ;
Valet, Philippe ;
Malavaud, Bernard ;
Muller, Catherine .
NATURE COMMUNICATIONS, 2016, 7
[25]   Obesity is associated with biochemical recurrence after radical prostatectomy: A multi-institutional extended validation study [J].
Maj-Hes, Agnes B. ;
Mathieu, Romain ;
Oezsoy, Mehmet ;
Soria, Francesco ;
Moschini, Marco ;
Abufaraj, Mohammad ;
Briganti, Alberto ;
Roupret, Morgan ;
Karakiewicz, Pierre I. ;
Klatte, Tobias ;
Shariat, Shahrokh F. .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (07) :460.e1-460.e8
[26]   The effect of BMI on clinicopathologic and functional outcomes after open radical prostatectomy [J].
Mandel, Philipp ;
Kretschmer, Alexander ;
Chandrasekar, Thenappan ;
Nguyen, Hao G. ;
Buchner, Alexander ;
Stief, Christian G. ;
Tilki, Derya .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (03) :297-302
[27]   Evaluation and Management of Testosterone Deficiency: AUA Guideline [J].
Mulhall, John P. ;
Trost, Landon W. ;
Brannigan, Robert E. ;
Kurtz, Emily G. ;
Redmon, J. Bruce ;
Chiles, Kelly A. ;
Lightner, Deborah J. ;
Miner, Martin M. ;
Murad, M. Hassan ;
Nelson, Christian J. ;
Platz, Elizabeth A. ;
Ramanathan, Lakshmi V. ;
Lewis, Ronald W. .
JOURNAL OF UROLOGY, 2018, 200 (02) :423-432
[28]  
Nimptsch K, 2016, RECENT RESULTS CANC, V208, P199, DOI 10.1007/978-3-319-42542-9_11
[29]   Obesity and Prostate Cancer: An Insight Into Postmodern Medicine [J].
Siddiqui, Sameer A. .
JOURNAL OF UROLOGY, 2009, 182 (01) :14-15
[30]   Association of obesity with tumor characteristics and treatment failure of prostate cancer in African-American and European American men [J].
Spangler, E. ;
Zeigler-Johnson, C. M. ;
Coomes, M. ;
Malkowicz, S. B. ;
Wein, A. ;
Rebbeck, T. R. .
JOURNAL OF UROLOGY, 2007, 178 (05) :1939-1944